Skip to main content
. Author manuscript; available in PMC: 2017 Dec 12.
Published in final edited form as: Biomacromolecules. 2016 Nov 29;17(12):3940–3948. doi: 10.1021/acs.biomac.6b01330

Figure 4.

Figure 4

Heparin concentration measured in ECM (A) immediately after treatment with PBS, heparin sodium, CBPi–heparin or CBP–heparin, and (B) up to 4 weeks after ECM modification. The dash line indicates baseline level of GAGs measured in ECM at t = 0 (n = 3).